JPH08503920A - 抗血栓ペプチドおよび偽ペプチド誘導体 - Google Patents

抗血栓ペプチドおよび偽ペプチド誘導体

Info

Publication number
JPH08503920A
JPH08503920A JP3510398A JP51039891A JPH08503920A JP H08503920 A JPH08503920 A JP H08503920A JP 3510398 A JP3510398 A JP 3510398A JP 51039891 A JP51039891 A JP 51039891A JP H08503920 A JPH08503920 A JP H08503920A
Authority
JP
Japan
Prior art keywords
aspartyl
valine
trifluoroacetate
guanidinocinnamoyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3510398A
Other languages
English (en)
Japanese (ja)
Inventor
スコット アイ クライン
ブルース エフ モリノ
ジェフリー エム ディナー
マーク ツェカイ
マイケル アール ベッカー
Original Assignee
ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド filed Critical ローヌ−プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド
Publication of JPH08503920A publication Critical patent/JPH08503920A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3510398A 1991-04-11 1991-04-11 抗血栓ペプチドおよび偽ペプチド誘導体 Pending JPH08503920A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1991/002471 WO1992018117A1 (fr) 1991-04-11 1991-04-11 Derives peptidiques et pseudopeptidiques antithrombotiques

Publications (1)

Publication Number Publication Date
JPH08503920A true JPH08503920A (ja) 1996-04-30

Family

ID=22225448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3510398A Pending JPH08503920A (ja) 1991-04-11 1991-04-11 抗血栓ペプチドおよび偽ペプチド誘導体

Country Status (4)

Country Link
EP (1) EP0584066A4 (fr)
JP (1) JPH08503920A (fr)
AU (1) AU661659B2 (fr)
WO (1) WO1992018117A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505846A (ja) * 1992-12-29 1996-06-25 スミスクライン・ビーチャム・コーポレイション 血小板凝集阻害用化合物
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
DK0825184T3 (da) * 1993-03-29 2001-09-10 Astrazeneca Ab Heterocykliske derivater som blodpladeaggregeringsinhibitorer
WO1994022835A2 (fr) * 1993-03-29 1994-10-13 Zeneca Limited Composes heterocycliques en tant qu'inhibiteurs de l'agregation plaquettaire
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
CZ291378B6 (cs) * 1993-10-15 2003-02-12 Aventis Pharmaceuticals Inc. Pseudopeptidové sloučeniny jako antitrombotické látky, farmaceutické prostředky obsahující tyto sloučeniny a meziprodukty
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105789A (en) * 1976-05-10 1978-08-08 E. R. Squibb & Sons, Inc. Carboxyalkylacylamino acids
JPS5753446A (en) * 1980-09-16 1982-03-30 Torii Yakuhin Kk Peptide derivative
US4634715A (en) * 1981-02-17 1987-01-06 Merck & Co., Inc. Aza analogs of carboxyalkyl dipeptide derivatives as antihypertensives
JPS606647A (ja) * 1983-06-17 1985-01-14 Microbial Chem Res Found アルフアメニン及びその関連化合物と合成法
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
CA2037153A1 (fr) * 1990-03-09 1991-09-10 Leo Alig Derives de l'acide acetique
GB9007751D0 (en) * 1990-04-05 1990-06-06 Ciba Geigy Ag Novel platelet-aggregation inhibitors
JPH06505978A (ja) * 1991-02-05 1994-07-07 スミスクライン・ビーチャム・コーポレイション 芳香族エステルまたはアミドを含有する抗凝集性ペプチド
IE920710A1 (en) * 1991-03-06 1992-09-09 Searle & Co Phenyl amidines derivatives useful as platelet aggregation¹inhibitors

Also Published As

Publication number Publication date
EP0584066A4 (fr) 1994-10-12
AU661659B2 (en) 1995-08-03
AU8089691A (en) 1992-11-17
WO1992018117A1 (fr) 1992-10-29
EP0584066A1 (fr) 1994-03-02

Similar Documents

Publication Publication Date Title
US5053392A (en) Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
JP2735298B2 (ja) 新規な血小板凝集阻害剤
US4952562A (en) Anti-thrombotic peptides and pseudopeptides
US5086069A (en) Anti-thrombotic peptide and pseudopeptide derivatives
US5051405A (en) Anti-thrombotic peptides and pseudopeptides
JP3347748B2 (ja) 新規な血小板凝集抑制剤
JP2000501382A (ja) 新規アミノ酸誘導体、それらの調製方法及びこれらの化合物を含む医薬組成物
JPH10510261A (ja) タンパク質：ファルネシルトランスフェラーゼの置換テトラーおよびペンタペプチド阻害剤
US5064814A (en) Anti-thrombotic peptide and pseudopeptide derivatives
JPH10502078A (ja) タンパク質ファルネシルトランスフェラーゼの阻害剤としてのヒスチジンおよびホモヒスチジン誘導体
JPH09504547A (ja) タンパク質：ファルネシルトランスフェラーゼの置換されたジ‐およびトリペプチド阻害剤
JP2002524571A (ja) ＶＩＩａ因子阻害剤
AU646411B2 (en) Anti-thrombotic peptides and pseudopeptides
CA2184824A1 (fr) Peptides antagonistes de type bradykinine, incorporant des derives de substitution en n de glycines
JPH06506699A (ja) 抗血栓性ペプチドおよび偽ペプチド
JPH08503920A (ja) 抗血栓ペプチドおよび偽ペプチド誘導体
US5332726A (en) Antithrombotic peptides and pseudopeptides
US5935932A (en) Bradykinin antagonists containing pentafluorophenylalanine
JP2918746B2 (ja) ペプチド誘導体およびその用途
JPH06306096A (ja) ペプチド誘導体及びその用途
US5328900A (en) Anti-thrombotic peptide and pseudopeptide derivatives
JP2617700B2 (ja) 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
JPH07316193A (ja) ペプチド誘導体およびその用途
JPH0597891A (ja) 血管弛緩ペプチド類
WO2004005328A2 (fr) Compose peptidomimetique utile en tant qu'inhibiteur d'integrines